In combination with a series of previous studies, we found that decreased ICAM1 mRNA levels predict poor prognoses in patients with lung cancer (Melis et al., 1996; Haustein et al., 2014; Schellhorn et al., 2015). This evidence concerns the gene ICAM1 and lung carcinoma.